Does lymphocyte-to-monocyte ratio before, during, or after definitive chemoradiation for locally advanced pancreatic cancer predict for clinical outcomes?

Giacomelli, Irene; Scartoni, Daniele; Mohammadi, Homan; Regine, William F; Chuong, Michael D

Giacomelli, Irene; Scartoni, Daniele; Mohammadi, Homan; Regine, William F; Chuong, Michael D.

Afiliación

Giacomelli I; Proton Treatment Center, APSS (Azienda Provinciale per i Servizi Sanitari), Trento, Italy.
Scartoni D; Proton Treatment Center, APSS (Azienda Provinciale per i Servizi Sanitari), Trento, Italy.
Mohammadi H; University of Maryland School of Medicine, Baltimore, MD, USA.
Regine WF; Radiation Oncology Department, University of Maryland, Baltimore MD, USA.
Chuong MD; Radiation Oncology Department, Miami Cancer Institute at Baptist Health South Florida, Miami, Florida, USA.

J Gastrointest Oncol ; 8(4): 721-727, 2017 Aug.

Article en En | MEDLINE | ID: mdl-28890823

Palabras clave

Pancreas; chemotherapy; lymphocyte; monocyte; radiotherapy

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Gastrointest Oncol Año: 2017 Tipo del documento: Article País de afiliación: Italia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google